A glimpse into long COVID and symptoms
- PMID: 35697054
- PMCID: PMC9187332
- DOI: 10.1016/S2213-2600(22)00217-X
A glimpse into long COVID and symptoms
Conflict of interest statement
CY and SJT report a grant from the Canadian Institutes of Health Research (grant number 177747). HZ declares no competing interests.
Comment in
-
A glimpse into long COVID and symptoms - Authors' reply.Lancet Respir Med. 2022 Sep;10(9):e82. doi: 10.1016/S2213-2600(22)00212-0. Epub 2022 Jun 10. Lancet Respir Med. 2022. PMID: 35697052 Free PMC article. No abstract available.
Comment on
-
Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study.Lancet Respir Med. 2022 Sep;10(9):863-876. doi: 10.1016/S2213-2600(22)00126-6. Epub 2022 May 11. Lancet Respir Med. 2022. PMID: 35568052 Free PMC article.
Similar articles
-
A glimpse into long COVID and symptoms - Authors' reply.Lancet Respir Med. 2022 Sep;10(9):e82. doi: 10.1016/S2213-2600(22)00212-0. Epub 2022 Jun 10. Lancet Respir Med. 2022. PMID: 35697052 Free PMC article. No abstract available.
-
COVID-19: Evaluation and Care of Patients With Persistent Symptoms Following Acute SARS-CoV-2 Infection.Ann Intern Med. 2021 Aug;174(8):1159-1160. doi: 10.7326/M21-2342. Epub 2021 Jun 11. Ann Intern Med. 2021. PMID: 34115532 Free PMC article.
-
Long COVID: which symptoms can be attributed to SARS-CoV-2 infection?Lancet. 2022 Aug 6;400(10350):411-413. doi: 10.1016/S0140-6736(22)01385-X. Lancet. 2022. PMID: 35933996 Free PMC article. No abstract available.
-
[Update 2021: COVID-19 from the perspective of neurology].Dtsch Med Wochenschr. 2021 Jul;146(13-14):918-923. doi: 10.1055/a-1449-5098. Epub 2021 Jul 13. Dtsch Med Wochenschr. 2021. PMID: 34256409 Review. German.
-
The endocrine system function disturbances during and after SARS-CoV-2 infection.Eur Rev Med Pharmacol Sci. 2022 Mar;26(6):2171-2178. doi: 10.26355/eurrev_202203_28365. Eur Rev Med Pharmacol Sci. 2022. PMID: 35363367 Review.
Cited by
-
Investigation into the restoration of TRPM3 ion channel activity in post-COVID-19 condition: a potential pharmacotherapeutic target.Front Immunol. 2024 May 3;15:1264702. doi: 10.3389/fimmu.2024.1264702. eCollection 2024. Front Immunol. 2024. PMID: 38765011 Free PMC article.
-
Long COVID: the next public health crisis is already on its way.Lancet Reg Health Eur. 2023 May;28:100612. doi: 10.1016/j.lanepe.2023.100612. Epub 2023 Mar 11. Lancet Reg Health Eur. 2023. PMID: 37131860 Free PMC article. No abstract available.
-
Omicron variants of SARS-CoV-2 and long COVID.Front Immunol. 2022 Dec 9;13:1061686. doi: 10.3389/fimmu.2022.1061686. eCollection 2022. Front Immunol. 2022. PMID: 36569883 Free PMC article.
-
Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial.Lancet Infect Dis. 2023 Oct;23(10):1119-1129. doi: 10.1016/S1473-3099(23)00299-2. Epub 2023 Jun 8. Lancet Infect Dis. 2023. PMID: 37302406 Free PMC article. Clinical Trial.
-
Outpatient treatment of Covid-19 with metformin, ivermectin, and fluvoxamine and the development of Long Covid over 10-month follow-up.medRxiv [Preprint]. 2022 Dec 23:2022.12.21.22283753. doi: 10.1101/2022.12.21.22283753. medRxiv. 2022. PMID: 36597543 Free PMC article. Preprint.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical